Overview
Bixia Tang practices in Beijing, China. Tang is rated as a Distinguished expert by MediFind in the treatment of Melanoma. Their top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Urothelial Cancer, and Upper Tract Urothelial Carcinoma (UTUC).
Their clinical research consists of co-authoring 115 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 63 articles in the study of Melanoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MelanomaTang isDistinguished. Learn about Melanoma.
- Advanced
- Renal Cell Carcinoma (RCC)
- Experienced
- Adult Soft Tissue SarcomaTang isExperienced. Learn about Adult Soft Tissue Sarcoma.
- DiarrheaTang isExperienced. Learn about Diarrhea.
- Lung MetastasesTang isExperienced. Learn about Lung Metastases.
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerTang isExperienced. Learn about Urothelial Cancer.